Cargando…

Oral Mucosa Derived α−Synuclein as a Potential Diagnostic Biomarker for Parkinson′s Disease

BACKGROUND: Pathological α-synuclein (α-Syn) is not only exclusive to the central nervous system (CNS) in Parkinson’s disease (PD), but also extended to biofluids and peripheral tissues including oral cavity. Both oral mucosa and nervous system are derived from ectodermal tissue, and potentially sha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yuanchu, Yu, Zhenwei, Zhao, Jiajia, Cai, Huihui, Wang, Zhan, Wang, Xuemei, Feng, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000972/
https://www.ncbi.nlm.nih.gov/pubmed/35418851
http://dx.doi.org/10.3389/fnagi.2022.867528
_version_ 1784685566349017088
author Zheng, Yuanchu
Yu, Zhenwei
Zhao, Jiajia
Cai, Huihui
Wang, Zhan
Wang, Xuemei
Feng, Tao
author_facet Zheng, Yuanchu
Yu, Zhenwei
Zhao, Jiajia
Cai, Huihui
Wang, Zhan
Wang, Xuemei
Feng, Tao
author_sort Zheng, Yuanchu
collection PubMed
description BACKGROUND: Pathological α-synuclein (α-Syn) is not only exclusive to the central nervous system (CNS) in Parkinson’s disease (PD), but also extended to biofluids and peripheral tissues including oral cavity. Both oral mucosa and nervous system are derived from ectodermal tissue, and potentially share common disease-specific characteristics. Oral mucosal exfoliative cytology is a non-invasive technique, which is an easily acceptable for patients and ordinary people. The purpose of this study was to determine the abnormal accumulation of α-Syn in oral mucosa of PD patients and to learn the diagnostic utility of oral mucosa α-Syn for PD. METHODS: The oral mucosa samples were obtained from 57 patients with PD and 51 age-matched controls by cytological brush. Immunofluorescence analysis was used to investigate the presence and subcellular localization of α-Syn, phosphorylated α-Syn at Ser129 (pS129) and oligomeric α-Syn in the oral mucosa cells of PD patients and controls. Images taken as Z-stacks were analyzed for 3D reconstruction to visualize the α-Syn intracellular localization. Then, the concentrations of α-Syn, pS129, and oligomeric α-Syn in oral mucosa samples were measured using electrochemiluminescence assays. RESULTS: Immunofluorescence images revealed the increased α-Syn, pS129, and oligomeric α-Syn levels in oral mucosa cells of PD patients than age-matched controls. The intracellular distributions of α-Syn species were determine by Z-stack images with 3D reconstruction, and α-Syn was detected in both the nucleus and cytoplasm. However, pS129 was mainly located in the cytoplasm, and oligomeric α-Syn was highly expressed in the nucleus and perinuclear cytoplasm. The concentrations of three α-Syn species were significantly increased in the oral mucosa cell samples of PD patients than controls (α-Syn, p = 0.001; pS129, p = 0.002; oligomeric α-Syn, p = 0.013). In PD patients, the oral mucosa α-Syn and oligomeric α-Syn levels were significantly correlated with Hoehn-Yahr scales (α-Syn, r = 0.495, p = 0.001; oligomeric α-Syn, r = 0.324, p = 0.03). The area under curve (AUC) of ROC analysis using an integrative model including α-Syn, pS129, and oligomeric α-Syn for PD diagnosis was 0.749, with 66.7% sensitivity and 72.5% specificity. CONCLUSION: This study for the first time demonstrated increased expressions of α-Syn, pS129, and oligomeric α-Syn in oral mucosa cells from PD patients, which serve as useful and non-invasive PD diagnostic biomarkers.
format Online
Article
Text
id pubmed-9000972
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90009722022-04-12 Oral Mucosa Derived α−Synuclein as a Potential Diagnostic Biomarker for Parkinson′s Disease Zheng, Yuanchu Yu, Zhenwei Zhao, Jiajia Cai, Huihui Wang, Zhan Wang, Xuemei Feng, Tao Front Aging Neurosci Neuroscience BACKGROUND: Pathological α-synuclein (α-Syn) is not only exclusive to the central nervous system (CNS) in Parkinson’s disease (PD), but also extended to biofluids and peripheral tissues including oral cavity. Both oral mucosa and nervous system are derived from ectodermal tissue, and potentially share common disease-specific characteristics. Oral mucosal exfoliative cytology is a non-invasive technique, which is an easily acceptable for patients and ordinary people. The purpose of this study was to determine the abnormal accumulation of α-Syn in oral mucosa of PD patients and to learn the diagnostic utility of oral mucosa α-Syn for PD. METHODS: The oral mucosa samples were obtained from 57 patients with PD and 51 age-matched controls by cytological brush. Immunofluorescence analysis was used to investigate the presence and subcellular localization of α-Syn, phosphorylated α-Syn at Ser129 (pS129) and oligomeric α-Syn in the oral mucosa cells of PD patients and controls. Images taken as Z-stacks were analyzed for 3D reconstruction to visualize the α-Syn intracellular localization. Then, the concentrations of α-Syn, pS129, and oligomeric α-Syn in oral mucosa samples were measured using electrochemiluminescence assays. RESULTS: Immunofluorescence images revealed the increased α-Syn, pS129, and oligomeric α-Syn levels in oral mucosa cells of PD patients than age-matched controls. The intracellular distributions of α-Syn species were determine by Z-stack images with 3D reconstruction, and α-Syn was detected in both the nucleus and cytoplasm. However, pS129 was mainly located in the cytoplasm, and oligomeric α-Syn was highly expressed in the nucleus and perinuclear cytoplasm. The concentrations of three α-Syn species were significantly increased in the oral mucosa cell samples of PD patients than controls (α-Syn, p = 0.001; pS129, p = 0.002; oligomeric α-Syn, p = 0.013). In PD patients, the oral mucosa α-Syn and oligomeric α-Syn levels were significantly correlated with Hoehn-Yahr scales (α-Syn, r = 0.495, p = 0.001; oligomeric α-Syn, r = 0.324, p = 0.03). The area under curve (AUC) of ROC analysis using an integrative model including α-Syn, pS129, and oligomeric α-Syn for PD diagnosis was 0.749, with 66.7% sensitivity and 72.5% specificity. CONCLUSION: This study for the first time demonstrated increased expressions of α-Syn, pS129, and oligomeric α-Syn in oral mucosa cells from PD patients, which serve as useful and non-invasive PD diagnostic biomarkers. Frontiers Media S.A. 2022-03-28 /pmc/articles/PMC9000972/ /pubmed/35418851 http://dx.doi.org/10.3389/fnagi.2022.867528 Text en Copyright © 2022 Zheng, Yu, Zhao, Cai, Wang, Wang and Feng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Zheng, Yuanchu
Yu, Zhenwei
Zhao, Jiajia
Cai, Huihui
Wang, Zhan
Wang, Xuemei
Feng, Tao
Oral Mucosa Derived α−Synuclein as a Potential Diagnostic Biomarker for Parkinson′s Disease
title Oral Mucosa Derived α−Synuclein as a Potential Diagnostic Biomarker for Parkinson′s Disease
title_full Oral Mucosa Derived α−Synuclein as a Potential Diagnostic Biomarker for Parkinson′s Disease
title_fullStr Oral Mucosa Derived α−Synuclein as a Potential Diagnostic Biomarker for Parkinson′s Disease
title_full_unstemmed Oral Mucosa Derived α−Synuclein as a Potential Diagnostic Biomarker for Parkinson′s Disease
title_short Oral Mucosa Derived α−Synuclein as a Potential Diagnostic Biomarker for Parkinson′s Disease
title_sort oral mucosa derived α−synuclein as a potential diagnostic biomarker for parkinson′s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000972/
https://www.ncbi.nlm.nih.gov/pubmed/35418851
http://dx.doi.org/10.3389/fnagi.2022.867528
work_keys_str_mv AT zhengyuanchu oralmucosaderivedasynucleinasapotentialdiagnosticbiomarkerforparkinsonsdisease
AT yuzhenwei oralmucosaderivedasynucleinasapotentialdiagnosticbiomarkerforparkinsonsdisease
AT zhaojiajia oralmucosaderivedasynucleinasapotentialdiagnosticbiomarkerforparkinsonsdisease
AT caihuihui oralmucosaderivedasynucleinasapotentialdiagnosticbiomarkerforparkinsonsdisease
AT wangzhan oralmucosaderivedasynucleinasapotentialdiagnosticbiomarkerforparkinsonsdisease
AT wangxuemei oralmucosaderivedasynucleinasapotentialdiagnosticbiomarkerforparkinsonsdisease
AT fengtao oralmucosaderivedasynucleinasapotentialdiagnosticbiomarkerforparkinsonsdisease